Published in Br Heart J on September 01, 1992
Screening for hypertrophic cardiomyopathy. BMJ (1993) 2.31
Athlete's heart. Heart (2003) 1.45
Racial differences in cardiac structure and function in essential hypertension. BMJ (1994) 1.27
Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J (1993) 0.98
Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS). Am Heart J (2009) 0.96
Prevalence of electrocardiographic abnormalities in West-Asian and African male athletes. Br J Sports Med (2011) 0.90
Left ventricular function in professional football players evaluated by tissue Doppler imaging and strain imaging. Int J Cardiovasc Imaging (2007) 0.89
Analysis of athletes' heart by tissue Doppler and strain/strain rate imaging. Int J Cardiovasc Imaging (2010) 0.84
Myocardial hypertrophy and its role in heart failure with preserved ejection fraction. J Appl Physiol (1985) (2015) 0.83
The role of new echocardiographic techniques in athlete's heart. F1000Res (2015) 0.75
Do big athletes have big hearts? Impact of extreme anthropometry upon cardiac hypertrophy in professional male athletes. Br J Sports Med (2012) 0.75
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978) 20.37
Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc (1978) 4.92
Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol (1988) 3.89
The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med (1991) 3.17
Sudden death in young athletes. Circulation (1980) 3.05
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
The athletic heart syndrome. N Engl J Med (1985) 2.19
Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography. Circulation (1985) 1.77
Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol (1986) 1.70
Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol (1984) 1.67
Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning. Am J Cardiol (1978) 1.36
Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients. J Am Coll Cardiol (1987) 1.30
Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function. Br Heart J (1988) 1.16
Doppler echocardiography for assessing left ventricular diastolic function. Ann Intern Med (1988) 1.13
Effect of heart rate on left ventricular diastolic transmitral flow velocity patterns assessed by Doppler echocardiography in normal subjects. Am J Cardiol (1991) 1.05
A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity. J Am Coll Cardiol (1987) 1.05
Physiologic hypertrophy: effects on left ventricular systolic mechanics in athletes. J Am Coll Cardiol (1987) 1.03
Left ventricular filling in endurance-trained subjects. J Am Coll Cardiol (1986) 1.02
Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol (1987) 0.98
Reproducibility of Doppler echocardiographic measurements of left ventricular diastolic function. Eur Heart J (1988) 0.98
Myocardial mechanics of athletic hearts in comparison with diseased hearts. Am Heart J (1983) 0.97
Noninvasive evaluation of exercise training in college-age men. Circulation (1981) 0.97
Left ventricular diastolic function in weight lifters. Am J Cardiol (1986) 0.96
Left ventricular diastolic function in elite athletes with physiologic cardiac hypertrophy. J Am Coll Cardiol (1985) 0.95
Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol (1986) 0.95
Assessment of stiffness of the hypertrophied left ventricle of bicyclists using left ventricular inflow Doppler velocimetry. J Am Coll Cardiol (1987) 0.94
The athlete's heart. Eur Heart J (1982) 0.92
Development and regression of left ventricular hypertrophy. J Am Coll Cardiol (1984) 0.88
Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophy. J Am Coll Cardiol (1985) 0.88
Left ventricular structure and function by echocardiography in ultraendurance athletes. Am J Cardiol (1986) 0.88
Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy. Am J Cardiol (1987) 0.87
Echocardiographic and Doppler flow observations in obstructed and nonobstructed hypertrophic cardiomyopathy. Am J Cardiol (1985) 0.82
Echocardiographic evaluation of the dimensions and systolic properties of the left ventricle in freshman athletes during physical training. Eur Heart J (1986) 0.79
Regional dysfunction by equilibrium radionuclide angiocardiography: a clinicopathologic study evaluating the relation of degree of dysfunction to the presence and extent of myocardial infarction. J Am Coll Cardiol (1987) 0.77
Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol (2000) 7.39
Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science (1998) 5.98
An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis) N Engl J Med (1998) 4.92
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med (1995) 4.37
Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med (1998) 4.29
The management of hypertrophic cardiomyopathy. N Engl J Med (1997) 4.15
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med (2000) 3.99
Profile of preparticipation cardiovascular screening for high school athletes. JAMA (1998) 3.36
The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med (1991) 3.17
Sudden death in young athletes. Circulation (1980) 3.05
Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.97
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J (2002) 2.75
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation (1979) 2.68
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol (1995) 2.62
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27
Prognosis of surgically corrected coarctation of the aorta. A 20-year postoperative appraisal. Circulation (1973) 2.21
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart (2008) 2.13
Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation (2000) 2.12
Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA (2000) 2.10
Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med (1999) 2.05
Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation (2000) 2.03
Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med (1986) 2.00
Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation (2001) 2.00
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol (1981) 1.89
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation (1982) 1.87
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Congenital coronary artery anomalies in young patients: new perspectives for timely identification. J Am Coll Cardiol (2001) 1.84
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1979) 1.80
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
"Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol (1978) 1.76
Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart (1997) 1.72
Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol (1986) 1.70
Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol (1984) 1.67
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation (1981) 1.66
Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.65
Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation (1982) 1.64
Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol (1979) 1.63
Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol (1986) 1.59
Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol (1975) 1.59
A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res (1998) 1.59
Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol (1987) 1.57
Asymetric septal hypertrophy in childhood. Circulation (1976) 1.56
Human heart and platelet actins are products of different genes. Science (1976) 1.55
Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol (1979) 1.55
Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy. J Am Coll Cardiol (1991) 1.53
Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol (1994) 1.52
Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. Am J Cardiol (1991) 1.48
Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol (2001) 1.47
Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1987) 1.46
Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol (2001) 1.44
Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol (1980) 1.42
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation (1979) 1.41
Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation (1977) 1.41
Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation (1991) 1.39
Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation (1995) 1.39
Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation (1991) 1.39
Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol (1995) 1.38
Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation (1999) 1.35
Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation (1978) 1.33
Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.32
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med (1988) 1.31
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation (1981) 1.30
Unusual evolution of acquired infundibular stenosis in patients with ventricular septal defect. Clinical and morphologic observations. Circulation (1973) 1.30
Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation (1992) 1.28
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation (1979) 1.26
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation (1979) 1.25
Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol (1995) 1.23
Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol (1983) 1.22
Potential role of QT interval prolongation in sudden infant death syndrome. Circulation (1976) 1.19
Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function. Br Heart J (1988) 1.16
Asymmetric septal hypertrophy (ASH) in infancy. Circulation (1974) 1.15
Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.15
Acidic fibroblast growth factor in the developing rat embryo. J Cell Biol (1991) 1.15
Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J (1982) 1.14
Cardiovascular involvement in osteogenesis imperfecta. Circulation (1986) 1.14
Identification of congenital malformations of the great arteries in infants by real-time two-dimensional echocardiography. Circulation (1975) 1.14
Myocardial ultrastructure in patients with chronic aortic valve disease. Am J Cardiol (1975) 1.13
Doppler echocardiography for assessing left ventricular diastolic function. Ann Intern Med (1988) 1.13